Evidence map›Paper›PMID 15735755›Full record

ArticleOncogene2005

PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts.

Stefano Cairo, Francesca De Falco, Mariateresa Pizzo, Paolo Salomoni, Pier Paolo Pandolfi, Germana Meroni

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Stefano CairoTelethon Institute of Genetics and Medicine, 80131 Naples, Italy.
Francesca De Falco
Mariateresa Pizzo
Paolo Salomoni
Pier Paolo Pandolfi
Germana Meroni
Telethon Institute Of Genetics And Medicine · ITCornell University · US

Funding

Telethon TGM03Z05Telethon TGM06S01
6 · The paper itself

Abstract

c-myc is a well-known proto-oncogene encoding for a transcription factor that needs to be tightly regulated in order to preserve cell homeostasis. The Promyelocytic Leukaemia gene product PML plays an important role in cell growth and survival, and resides in discrete subnuclear structures called Nuclear Bodies (NB). We performed comparative analysis of the expression of 40 Myc target genes and of Myc binding to their regulatory regions both in wild-type and PML knockout cells. We demonstrate that if PML is absent, despite Myc binding to the DNA regulatory sequences is unchanged, the expression profile of several Myc target genes is altered. PML is largely involved in gene regulation, via recruitment of several transcription factors and cofactors to the NB. Consistently, we show that Myc partially localizes to the NB and physically interacts with PML, and that this localization depends on Myc expression levels. As deregulation occurs to both activated and repressed Myc target genes, we propose that PML influences Myc transcriptional activity through a mechanism that involves the control of Myc post-translational modifications.

Indexed as

AnimalsFibroblastsGene Expression RegulationGenes, mycMiceNeoplasm ProteinsNuclear ProteinsPolymerase Chain ReactionPromyelocytic Leukemia ProteinProtein Processing, Post-TranslationalProto-Oncogene Proteins c-mycRNATranscription FactorsTransfectionTumor Suppressor ProteinsNeoplasm ProteinsNuclear ProteinsPml protein, mousePromyelocytic Leukemia ProteinProto-Oncogene Proteins c-mycRNATranscription FactorsTumor Suppressor Proteins

Identifiers

PMID15735755
OpenAlexW2054413834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.